Brief: Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt As Chief Medical Officer
18/02/2026 12:24
Feb 18 (Reuters) - Aquestive Therapeutics Inc AQST.O: AQUESTIVE THERAPEUTICS APPOINTS INTERNATIONALLY RECOGNIZED ALLERGIST DR. MATTHEW GREENHAWT AS CHIEF MEDICAL OFFICER Source text: ID:nGNX7yWT5J Further company coverage: AQST.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing
Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income
Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film
Aquestive misses Q4 revenue estimates, EBITDA loss widens
Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million